[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5357 Introduced in House (IH)]

<DOC>






116th CONGRESS
  1st Session
                                H. R. 5357

To amend the Public Health Service Act to authorize a pilot program to 
   develop, expand, and enhance the commercialization of biomedical 
                   products, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                            December 6, 2019

  Mr. Peters introduced the following bill; which was referred to the 
                    Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
To amend the Public Health Service Act to authorize a pilot program to 
   develop, expand, and enhance the commercialization of biomedical 
                   products, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Innovation Network and Capital Act 
of 2019''.

SEC. 2. PILOT PROGRAM FOR RESEARCH STARTUPS.

    Part A of title IV of the Public Health Service Act (42 U.S.C. 281 
et seq.) is amended by adding at the end the following:

``SEC. 404O. PILOT PROGRAM FOR RESEARCH STARTUPS.

    ``(a) Funds.--The Director of NIH shall award grants or contracts 
to eligible entities to develop, expand, and enhance the 
commercialization of biomedical products.
    ``(b) Eligible Entity.--In this section, the term `eligible entity' 
means an entity receiving funding under--
            ``(1) the Small Business Innovation Research program of the 
        National Institutes of Health; or
            ``(2) the Small Business Technology Transfer program of the 
        National Institutes of Health.
    ``(c) Use of Funds.--An eligible entity shall use the funds 
received through such grant or contract to support--
            ``(1) the Commercialization Readiness Pilot program of the 
        National Institutes of Health;
            ``(2) the Innovation Corps program of the National 
        Institutes of Health;
            ``(3) the Commercialization Accelerator program of the 
        National Institutes of Health;
            ``(4) the Commercialization Assistance program of the 
        National Institutes of Health; and
            ``(5) such other programs and activities as the Director of 
        NIH determines to be appropriate, to support the 
        commercialization stage of research, later stage research and 
        development, technology transfer, and commercialization 
        technical assistance.
    ``(d) NIH Startup Support Account.--
            ``(1) Establishment.--There is established in the Treasury 
        an account, to be known as the NIH Startup Support Account, for 
        purposes of carrying out this section.
            ``(2) Transfer of funds.--There shall be transferred to the 
        NIH Startup Support Account from the general fund of the 
        Treasury, $100,000,000 for each of fiscal years 2021 through 
        2025, to be available until expended without further 
        appropriation.''.
                                 <all>